Expressive

rs11749255 (MSX2): Resistant Hypertension Variant

Key takeaways

  • rs11749255, near the MSX2 gene (HIGD1AP3 - MSX2 locus), is linked to resistant hypertension, a condition where blood pressure stays uncontrolled despite multiple medications.
  • In a meta-analysis of two independent studies, carriers of the risk allele had about 60% higher odds of resistant hypertension (odds ratio 1.60, 95% CI: 1.3-1.9).
  • The finding reached genome-wide significance (p = 3.8 x 10^-8), the accepted threshold for reliable genetic associations.
  • The association held in both a coronary artery disease cohort and a separate stroke cohort, suggesting it is not limited to one cardiovascular condition.

Key takeaways

  • rs11749255, near the MSX2 gene (HIGD1AP3 - MSX2 locus), is linked to resistant hypertension, a condition where blood pressure stays uncontrolled despite multiple medications.
  • In a meta-analysis of two independent studies, carriers of the risk allele had about 60% higher odds of resistant hypertension (odds ratio 1.60, 95% CI: 1.3-1.9).
  • The finding reached genome-wide significance (p = 3.8 x 10^-8), the accepted threshold for reliable genetic associations.
  • The association held in both a coronary artery disease cohort and a separate stroke cohort, suggesting it is not limited to one cardiovascular condition.

What the research says A genome-wide association study (GWAS) in White and Hispanic participants with hypertension and coronary artery disease identified rs11749255, located in the MSX2 gene region (also annotated as the HIGD1AP3 - MSX2 locus), as a genome-wide significant signal for resistant hypertension (RHTN). RHTN is defined as blood pressure that stays uncontrolled despite at least three antihypertensive medications, or that requires four or more drugs to remain controlled. The variant was discovered in 1,194 participants (odds ratio 1.50, 95% CI: 1.2-1.8, p = 7.3 x 10^-5), independently replicated in 585 participants (odds ratio 2.0, 95% CI: 1.4-2.8, p = 4.3 x 10^-5), and the combined meta-analysis yielded an odds ratio of 1.60 (95% CI: 1.3-1.9, p = 3.8 x 10^-8).

Reported associations

  • Resistant hypertension (INVEST-GENES discovery, n = 1,194): In White and Hispanic participants with hypertension and coronary artery disease, the variant was associated with RHTN with an odds ratio of 1.50 (95% CI: 1.2-1.8, p = 7.3 x 10^-5).
  • Resistant hypertension (SPS3-GENES replication, n = 585): In White and Hispanic participants with hypertension and a history of subcortical stroke, the association replicated with an odds ratio of 2.0 (95% CI: 1.4-2.8, p = 4.3 x 10^-5).
  • Resistant hypertension (meta-analysis): Combined analysis across both cohorts reached genome-wide significance (odds ratio 1.60, 95% CI: 1.3-1.9, p = 3.8 x 10^-8).

Evidence quality The association was identified in a GWAS (n = 1,194, INVEST-GENES) and replicated in an independent cohort (n = 585, SPS3-GENES), with a meta-analysis p-value of 3.8 x 10^-8 exceeding the standard genome-wide significance threshold of p < 5 x 10^-8. Both cohorts consisted of White and Hispanic participants, which limits generalizability to other ancestry groups. The discovery cohort enrolled patients with coronary artery disease while the replication cohort enrolled patients with subcortical stroke history, and the association was consistent across these two distinct clinical settings. A secondary validation look-up in a third dataset (eMERGE) was mentioned in the study, but full results were not available in the provided study materials. The combined primary sample size of approximately 1,800 participants is modest, and larger multi-ancestry studies would strengthen confidence in this finding.

Lifestyle considerations No lifestyle considerations on file for this variant.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Diet

  • dietary sodium restriction Moderate

    Sodium sensitivity contributes to BP resistance. Reduced sodium intake is recommended for resistant hypertension management and may help prevent onset.

    Target less than 2.3g sodium daily; monitor intake and discuss with healthcare provider

Discuss with your doctor

  • cardiovascular risk assessment for resistant hypertension Moderate

    This variant is robustly associated with resistant hypertension risk. Proactive discussion with healthcare providers enables early intervention strategies.

    Discuss rs11749255 carrier status and personalized RHTN prevention strategies at next visit

Screening

  • regular blood pressure monitoring Moderate

    Carriers of the rs11749255 A allele have 60% increased odds of resistant hypertension, requiring closer monitoring to detect early onset.

    Check blood pressure at least quarterly; track readings at home regularly

Frequently asked questions

What is rs11749255?

rs11749255 is a genetic variant (a single nucleotide polymorphism, or SNP) located in or near the MSX2 gene, also designated as the HIGD1AP3 - MSX2 locus. Research has linked it to resistant hypertension, a condition where blood pressure remains uncontrolled despite treatment with multiple medications.

What is resistant hypertension?

Resistant hypertension (RHTN) is defined as blood pressure that stays uncontrolled on at least three antihypertensive medications, or that requires four or more drugs to stay controlled. It is associated with higher risk of adverse outcomes including stroke, heart failure, and kidney disease.

What gene is rs11749255 near?

rs11749255 is located in or near the MSX2 gene region, also annotated as the HIGD1AP3 - MSX2 locus. The study that identified this variant did not characterize the specific biological mechanism by which this gene region may influence blood pressure.

Has the link between rs11749255 and resistant hypertension been replicated?

Yes. The association was first found in 1,194 hypertensive patients with coronary artery disease (INVEST-GENES study) and then independently replicated in 585 hypertensive patients with subcortical stroke history (SPS3-GENES study). The combined analysis reached genome-wide significance.

What does the odds ratio for rs11749255 mean in plain language?

An odds ratio of 1.60 from the meta-analysis indicates that carriers of the risk allele had roughly 60% higher statistical odds of having resistant hypertension compared to non-carriers in these study populations. This is a population-level statistical finding, not a personal risk calculation.